Harvard Bioscience, Inc. HBIO
Set alert
8.60 USD -0.30 -3.37%
At close · Nov 2
8.60 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
8.60 Day range 9.10
4.00 52-week range 9.10
- YTD
- +28.36%
- 1 year
- +65.38%
- Open
- 9.00
- Prev close
- 8.90
- Mkt cap
- 39.15M
- Vol
- 28.61K
- Avg vol
- 19.51K
- EPS
- -2.31
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.60
- High
- 9.10
- Forward P/E
- 14.00
- Beta
- 1.31
- Short ratio
- 2.66
- Inst. own
- 75.99%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.30
- 200-d avg
- 3.04
- 1y target
- 6.25
5D chart
Signals (72)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Nov 2, 2:05 PM | 17 hours ago |
| SMA: Bearish | Nov 2, 1:00 PM | 18 hours ago |
| SMA: Bearish | Nov 2, 1:00 PM | 18 hours ago |
| RSI: Oversold | Nov 2, 1:00 PM | 18 hours ago |
| MACD: Sell Signal | Nov 2, 10:35 AM | 21 hours ago |
| SMA: Bearish | Nov 2, 10:25 AM | 21 hours ago |
| SMA: Bullish | Nov 2, 10:10 AM | 21 hours ago |
| RSI: Overbought | Nov 2, 10:10 AM | 21 hours ago |
| SMA: Bearish | Nov 2, 10:00 AM | 21 hours ago |
| RSI: Overbought | Oct 30, 3:40 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:35 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:30 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:30 PM | 3 days ago |
| RSI: Overbought | Oct 30, 2:25 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 12:35 PM | 3 days ago |
| SMA: Bearish | Oct 30, 11:15 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 10:45 AM | 3 days ago |
| RSI: Overbought | Oct 30, 9:40 AM | 3 days ago |
| SMA: Bullish | Oct 29, 3:50 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 3:50 PM | 4 days ago |
Newest 20 of 72.
Analyst view
Consensus: none
Price target (mean) 6.25 -27.3% downside
Now 8.60
- Target (low)
- 5.50
- Target (mean)
- 6.25
- Target (high)
- 7.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.05 | 0.04 – 0.06 | 0.04 | +25.0% | 24.15M | -14.2% | 2 |
| Next quarter | 0.015 | -0.01 – 0.04 | 0.02 | -25.0% | 22.95M | -6.4% | 2 |
| Current year | 0.045 | 0.00 – 0.09 | 0.14 | -67.9% | 93.75M | -16.5% | 2 |
| Next year | 0.125 | 0.07 – 0.18 | 0.045 | +177.8% | 97.80M | +4.3% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 22, 2023 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| Apr 26, 2023 | Benchmark | Maintained | — | Buy |
| Apr 26, 2023 | Keybanc | Maintained | — | Overweight |
| Mar 10, 2023 | Benchmark | Reiterated | — | Buy |
| Nov 9, 2022 | Keybanc | Maintained | — | Overweight |
| Aug 5, 2022 | Keybanc | Maintained | — | Overweight |
| Nov 10, 2020 | Keybanc | Initiated | — | Overweight |
| Feb 27, 2020 | Benchmark | Maintained | — | Speculative Buy |
| Nov 17, 2016 | Singular Research | Initiated | — | Buy |
| Jul 28, 2015 | Benchmark | Initiated | — | Buy |
| Nov 26, 2013 | Sidoti & Co. | Upgrade | Neutral | Buy |